Monday, December 23, 2024
HomeTagsJazz Pharmaceuticals

Jazz Pharmaceuticals

Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2b Clinical Trial Evaluating Novel Suvecaltamide (JZP385) for Once-Daily Treatment of Adults with Essential Tremor

Jazz Pharmaceuticals plc announced that the first patient has been enrolled in a global Phase 2b clinical trial evaluating the safety and efficacy of...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics